Table 7.

Association of genotype with chronic GVHD

Genotypet testP
RIFNγIntron1-3/3 −1.06 .298 
RIFNγIntron1-3+ −0.58 .563 
RIFNγIntron1-2/2 +0.76 .450 
RIFNγIntron1-2+ +1.44 .156 
RIL-6−174GG +2.90 .005 
RIL-6−174G+ +1.64 .116 
DIFNγIntron1-3/3 +0.14 .890 
DIFNγIntron1-3+ +0.50 .312 
DIFNγIntron1-2/2 −0.97 .352 
DIFNγIntron1-2+ +0.96 .283 
DIL-6−174GG +1.95 .057 
DIL-6−174G+ +0.64 .524 
Genotypet testP
RIFNγIntron1-3/3 −1.06 .298 
RIFNγIntron1-3+ −0.58 .563 
RIFNγIntron1-2/2 +0.76 .450 
RIFNγIntron1-2+ +1.44 .156 
RIL-6−174GG +2.90 .005 
RIL-6−174G+ +1.64 .116 
DIFNγIntron1-3/3 +0.14 .890 
DIFNγIntron1-3+ +0.50 .312 
DIFNγIntron1-2/2 −0.97 .352 
DIFNγIntron1-2+ +0.96 .283 
DIL-6−174GG +1.95 .057 
DIL-6−174G+ +0.64 .524 

Univariable analysis of association of genotype with cGVHD by Kruskal-Wallis test. Recipient IL-6−174 genotype associates with cGvHD.

R inicates recipient; D, donor.

Close Modal

or Create an Account

Close Modal
Close Modal